FRIDAY, JUNE 21. Epidemiology/ Genetics. Symposium The Big Picture Genetic Architecture of Diabetes Room S 103 B

Transcription

1 Registration Hours: 9:00 a.m. 6:30 p.m. Shop Store Hours: 9:00 a.m. 6:30 p.m. FRIDAY, JUNE 21 Noon 12:40 p.m. Meet the Expert Sessions 12:50 p.m. 1:30 p.m. Meet the Expert Sessions 2:00 p.m. 4:00 p.m. The Kidney s Unholy Triad Obesity, Hypertension, and Hyperglycemia The Spectrum of Gluten-Related Disorders A Dual Challenge in Maximizing Cost- Effectiveness of Prevention and Treatment Practical Strategies in Older Adults The Big Picture Genetic Architecture of The Brain and the Periphery What s New in In Vivo Study Methods? Informatics, Biomarkers, and Imaging Beta Cell Failure in Type 1 Cause or Consequence? 4:15 p.m. 6:15 p.m. Inflammation, Cardiovascular Disease, and New Findings from Controlled Behavioral Interventions The Effect of Low Testosterone on Glycemic Control and Health in and Obesity The Journey to a Viable Artificial Pancreas Joint ADA/JDRF Global Epidemiology of Type 1 and Implications for Public Health Novel Metabolic Mediators of Energy Homeostasis Hypothalamic Inflammation and Metabolic Disturbance Preclinical Macronutrients, Muscle, and Other Hormones Development and Postnatal Growth of Islets ADA President s Oral Session I 8:00 p.m. 10:00 p.m. Opening Reception The Field Museum (Ticketed Event)

2 Registration Hours: 7:30 a.m. 6:30 p.m. Shop Store Hours: 7:30 a.m. 6:15 p.m. SATURDAY, JUNE 22 Exhibit Hall Hours: 10:00 a.m. 4:00 p.m. Poster Hall Hours: 10:00 a.m. 6:00 p.m. 8:00 a.m. 10:00 a.m. Hypoglycemia in Clinical Practice The Broad Spectrum of Diabetic Neuropathies from Cell Culture to Man 1:45 p.m. 3:45 p.m. Osteomyelitis in the Diabetic Foot Emerging Issues in Diabetic Nephropathy Risks, Mechanisms, and Treatment 4:00 p.m. 6:00 p.m. New Insights Into Treatment of Diabetic Retinopathy and Other The Burden of Diabetic Foot Disease (With Roger Pecoraro Award Lecture) ADA Education Recognition Program Making a Case for Education The Use of a National Education Database Exercise Mechanisms of Action Should Sulfonylureas Remain an Acceptable First-Line Add-On Therapy to Metformin? New Therapeutic Targets in Type 2 Mellitus ADA Care GLP-1 Agonists in Practice Gestational Management and Effects on Offspring (With Norbert Freinkel Award Lecture) Obesity-Related and Other Novel Predictors of Clinical Trials of T-Cell for Reversing Type 1 Insulin Action in Unexpected Sites 10:15 a.m. 11:15 a.m. President, Health Care & Education Address and Outstanding Educator in Award Lecture W 375 A 11:30 a.m. 1:30 p.m. General Poster Session/Guided Audio Poster Tours Hall F1 Noon 1:15 p.m. Professional Section Interest Group Discussions Education What Matters? Behavioral Science Contributions to Understanding (With Richard R. Rubin Award Lecture) The Future of Exercise Mimetics New Insights Into Mechanisms of Exercise Behavioral Interventions for Evidence From Recent Intervention Studies Continuous Glucose Monitoring (CGM) in the Management of in Pregnancy Pharmacologic Management of Obesity Novel The Future Is Now Changing Health Care Delivery Models In Utero and Beyond Insulin Resistance, Puberty, and Pregnancy in Pediatric China Medical Tribune Updating Research in China From Bench to Real World DCCT/EDIC 30th Anniversary Contributions and Progress Pediatric and Young Adult Implications for Metabolic Health in Later Life Genome-Wide Association Study and Beyond Transplant Therapies for Type 1 Current, Emerging, and Novel Islet for the Treatment of Type 1 6:15 p.m. 7:30 p.m. Networking Reception Central Concourse Level 3 (West Building) Mechanisms of Nutrient Stress Fat The White and the Brown Clock Genes in Homeostasis and Disease The Good, the Bad, and the Brown Fat Joint ADA/EASD Metabolic Effects of Bariatric Surgery How Low Can You Go? Improving Glucose With Bariatric Surgery Mechanisms of Action Neural Regulation of Glucose Fetal Programming of Beta Cell Function and Mass Lipid Signaling in the Beta Cell New Insights Into Islet Inflammation

3 Registration Hours: 7:30 a.m. 5:00 p.m. Shop Store Hours: 7:30 a.m. 6:45 p.m. SUNDAY, JUNE 23 WEAR RED TO STOP DIABETES Exhibit Hall Hours: 10:00 a.m. 4:00 p.m. Poster Hall Hours: 7:30 a.m. 6:30 p.m. 8:00 a.m. 10:00 a.m. Small Fiber Dysfunction in the Natural History of Diabetic Neuropathies in Type 1 and Type 2 From the Bench to the Bedside Advances in the Pathogenesis and Treatment of Diabetic Retinopathy A Brave New World Self-Management Support in the Community From Nutrients to Meals How Food Affects Control Applying New Technologies to Advance the Study of Maternal-Infant Outcomes in Obese and Diabetic Women and the Bones Closing the Communication Loop Technology Update in Pediatric Epidemiology of Risk Factors and in Special Populations Islet Autotransplantation Following Total Pancreatectomy for Chronic Pancreatitis State-of-the-Art Hematopoietic Cells and Insulin Action Gastrointestinal Regulation of Glucose Beta Cell Signal Transduction 2:15 p.m. 4:15 p.m. Oh, My Aching Feet Painful Diabetic Neuropathy of the Feet Cellular Mechanisms of Cardiovascular Disease in (With Edwin Bierman Award Lecture) Updates and Applications of Continuous Glucose Monitoring 10:15 a.m. 11:45 a.m. President, Medicine & Science Address and Banting Medal for Scientific Achievement Award Lecture W 375 A E Noon 2:00 p.m. General Poster Session/Guided Audio Poster Tours Hall F1 12:30 p.m. 1:45 p.m. Professional Section Interest Group Discussions Dietary Sweeteners Research, Recommendations, and the Real World Exercise as Adjunct Therapy for Insulin Sensitivity and NDEP New Science Implications for Care Quality Care Measures Can Unfavorably Impact Individual Care Update on New Insulin Preparations for the Management of Improving Health Care Delivery Kelly West Award for Outstanding Achievement in Epidemiology Lecture (2:15 p.m. 3:00 p.m.) Novel Disease Markers in Type 1 GLUT4 and Insulin Signaling Sleep, Circadian Rhythm, and Metabolic Consequences Phenotyping the Engineered Beta Cell Navigating the Spectrum Obesity, Insulin Resistance, and Type 2 in Youth

4 SUNDAY, JUNE 23 (continued) 4:30 p.m. 6:30 p.m. Novel Insights Into Diabetic Cardiomyopathy Hypoglycemia Novel Concepts Education Recharged and Technology Sleep A Novel Behavioral Target in? Persistent Microalbuminuria as an Adequate Indication of Renin-Angiotensin- Aldosterone System (RAAS) Blocking Therapies Non-Glycemic Effects of Incretin-Based Therapy Glucagon- Like Peptide-1 (GLP- 1) and Dipeptidyl Peptidase-4 (DPP-4) Environmental Risk Factors for Type 2 Epidemiologic and Mechanistic Evidence Human Immunology in Clinical Trials NAD Biology and Energy Regulation Role of the Brainstem in Regulation The Failing Beta Cell in Type 2 Joint ADA/AACC Newer Biomarkers in Do They Add Value? On the Horizon Selective Sodium Glucose Co-Transporter Inhibition

5 6:30 a.m. 7:30 a.m. Registration Hours: 7:30 a.m. 4:00 p.m. Shop Store Hours: 7:30 a.m. 6:45 p.m. MONDAY, JUNE 24 Exhibit Hall Hours: 10:00 a.m. 2:00 p.m. Poster Hall Hours: 7:30 a.m. 2:00 p.m. 8:00 a.m 10:00 a.m. So Your Patient Has Diabetic Kidney Disease Now What? Hypoglycemia Mechanisms and Clinical Aspects 2:15 p.m. 4:15 p.m. Joint ADA/ASN From Mice to Men and Back in Diabetic Kidney Disease Mealtime Insulin Dosing It s More Than Counting Carbohydrates Moving Toward a Cure in Type 1 Cost-Effective Health Care/Economics Fats and the Fetus Epidemiology of and Mortality The Anti-Islet Immune Response Mitochondrial Metabolic Functions Beyond OXPHOS Inflammation in Tissue 10:15 a.m. 11:45 a.m. National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture W 375 A E Noon 2:00 p.m. General Poster Session/Guided Audio Poster Tours Hall F1 12:30 p.m. 1:45 p.m. Professional Section Interest Group Discussions Diabetic Dyslipidemia What Influences Patients Risk Perception and Decision Making for Prevention and Control? In a Patient Who Is Failing Oral Antidiabetic Agent Therapy, the Next Step Is To? Nonprescription Therapies for Mellitus The Broad Spectrum of Education Strategies for Delivery Metabolically Healthy Obesity (MHO) and Metabolically Obese Normal Weight (MONW) New Insights and Advances Applications of Exome and Whole Genome Sequencing Lipotoxicity and Insulin Resistance Truth or Consequence? (Animals) Hepatic and Islet Function Electrical Activity and Pathways to Beta Cell Apoptosis Inpatient Management of 4:30 p.m. 6:30 p.m. Managing the Less Common Lipid Disorders Macrovascular Disease in Clinical Studies Intensifying Therapy Using Technology and Teams Update on in Pregnancy in Women With Pre-Existing Primary Results of the Look AHEAD Randomized Controlled Trial of a Lifestyle Intervention in Overweight and Obese Individuals With Type 2 Current Concepts in Nutritional Epidemiology and Metabolic Risk Islet Autotransplantation for the Prevention of Surgical New Mediators of Inter- Organ Metabolic Cross Talk Postprandial Hot Topics Stimulus-Secretion Coupling and Emerging Evidence in Pediatric Type 1

6 Registration Hours: 7:30 a.m. 10:30 a.m. Shop Store Hours: 7:30 a.m. 12:30 p.m. TUESDAY, JUNE 25 8:00 a.m. 10:00 a.m. Defective Hypoglycemia Counterregulation in Mellitus Mechanisms, Prevention, and Reversal Keeping Weight Off Does Diet Macronutrient Composition Matter? Pros and Carbs Exercise and Lipid Obesity Management for the Practicing Clinician New Information on DPP-4 Inhibition Milking the Genome-Wide Association Study (GWAS) Practical Applications for Metabolic Disease Bugs Inside and Out MicroRNA in Regulation Engineering a Beta Cell A Road Map 10:15 a.m. 12:15 p.m. Current State of Insulin Pump Therapy ADA President s Oral Session II